This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Georgopapadakou, N H
Right arrow Articles by Funke, P T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Georgopapadakou, N H
Right arrow Articles by Funke, P T

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1987 January; 31(1): 46-51

Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans.

N H Georgopapadakou, B A Dix, S A Smith, J Freudenberger and P T Funke

ABSTRACT

Eight antifungal agents were examined for effects on lipid biosynthesis and membrane integrity in Candida albicans. Lipids were labeled in vivo or in vitro with [14C]acetate and analyzed by thin-layer and gas chromatography. Membrane integrity was measured by a recently developed [14C]aminoisobutyric acid radiolabel release assay. The imidazole antifungal agents miconazole, econazole, clotrimazole, and ketoconazole, at concentrations inhibiting ergosterol biosynthesis (0.1 microM), decreased the ratio of unsaturated to saturated fatty acids in vivo but not in vitro. Similarly, naftifine, tolnaftate, and the azasterol A25822B, at concentrations inhibiting ergosterol biosynthesis (10, 100, and 1 microM, respectively), decreased the ratio of unsaturated to saturated fatty acids in vivo only. This suggests that the effect on fatty acids observed with ergosterol biosynthesis inhibitors may be secondary to the effect on ergosterol. With imidazoles, oleic acid antagonized inhibition of cell growth but not inhibition of ergosterol. This suggests that, with the C-14 demethylase inhibitors, decreased unsaturated fatty acids, rather than decreased ergosterol, are responsible for growth inhibition. Cerulenin, previously reported to be a potent inhibitor of both fatty acid and ergosterol biosynthesis, was found in the present study to inhibit the former (at 5 microM) but not the latter (up to 100 microM). Of the antifungal agents tested, econazole and miconazole (at 100 microM) produced complete release of [14C]aminoisobutyric acid, which is consistent with membrane damage.


Antimicrob Agents Chemother. 1987 January; 31(1): 46-51




This article has been cited by other articles:

  • Stone, G. W., Zhang, Q., Castillo, R., Doppalapudi, V. R., Bueno, A. R., Lee, J. Y., Li, Q., Sergeeva, M., Khambatta, G., Georgopapadakou, N. H. (2004). Mechanism of Action of NB2001 and NB2030, Novel Antibacterial Agents Activated by {beta}-Lactamases. Antimicrob. Agents Chemother. 48: 477-483 [Abstract] [Full Text]  
  • PINA-VAZ, C., SANSONETTY, F., RODRIGUES, A. G., MARTINEZ-DE-OLIVEIRA, J., FONSECA, A. F., MARDH, P.-A. (2000). Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species. J Med Microbiol 49: 831-840 [Abstract] [Full Text]  
  • Hahn, R. C., Hamdan, J. S. (2000). Effects of Amphotericin B and Three Azole Derivatives on the Lipids of Yeast Cells of Paracoccidioides brasiliensis. Antimicrob. Agents Chemother. 44: 1997-2000 [Abstract] [Full Text]